Evogene earnings beat, revenue fell short of estimates

This post was originally published on this site

Evogene’s stock price closed at $0.780. It is up 30.000% in the last 3 months and down -36.690% in the last 12 months.

Evogene saw 1 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Evogene’s stock price’s past reactions to earnings here.

According to InvestingPro, Evogene’s Financial Health score is “fair performance“.

Check out Evogene’s recent earnings performance, and Evogene’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar